Описание

Revolutionize healthcare collaboration:
our app seamlessly connects doctors and pharmaceutical companies through secure video calls, empowers professional networking, streamlines resource access, and features dedicated pages for companies to showcase products and activities, ensuring timely updates reach doctors effortlessly.
1. Secure Video Calls:
Connect doctors and pharmaceutical companies effortlessly through secure video calls, enabling real-time communication and collaboration.
2. Professional Networking:
Empower doctors to share ideas, discuss activities, and stay connected within a dedicated professional network, fostering a community of knowledge exchange.
3. Efficient Product Availability Search:
Streamline access to essential resources with a comprehensive search feature, allowing doctors to easily check product availability and make informed decisions.
4. Innovative Healthcare Collaboration:
Elevate the standard of collaboration in healthcare by providing a robust platform that seamlessly integrates video calls, networking, and resource availability.
5. Enhanced Communication:
Facilitate effective and secure communication between healthcare professionals and pharmaceutical experts, fostering a collaborative environment for improved patient care.
6. User-Friendly Interface:
Enjoy a user-friendly interface that enhances the overall experience, making the application intuitive and easy to navigate for healthcare professionals.
7. Dedicated Pharmaceutical Company Pages:
Provide pharmaceutical companies with professional pages to showcase their products, activities, and new items, offering a centralized hub for information dissemination.
8. Timely Updates for Doctors:
Ensure doctors stay informed about pharmaceutical companies' latest products, activities, and announcements through the platform, fostering a dynamic exchange of information.
9. Centralized Information Hub:
Create a centralized space where pharmaceutical companies can actively engage with doctors, keeping them abreast of new developments and offerings in the healthcare industry.
10. Effortless Information Access:
Enable doctors to effortlessly access and stay updated on pharmaceutical companies' profiles, promoting a seamless flow of information critical to informed decision-making in healthcare practices.
Скрыть Показать больше...

Скриншоты

Etisal RX Частые Вопросы

  • Приложение Etisal RX бесплатное?

    Да, Etisal RX полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли Etisal RX фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит Etisal RX?

    Приложение Etisal RX бесплатное.

  • Сколько зарабатывает Etisal RX?

    Чтобы получить оценку дохода приложения Etisal RX и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей

5 из 5

1 оценок в Соединенные Штаты

5 star
1
4 star
0
3 star
0
2 star
0
1 star
0
История оценок

Etisal RX Отзывы Пользователей

У приложения еще нет отзывов

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

Etisal RX Установки

30дн.

Etisal RX Доход

30дн.

Etisal RX Доходы и Загрузки

Получите ценные инсайты о производительности Etisal RX с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.

Информация о приложении

Категория
Social Networking
Языки
English
Последнее обновление
0.1.6 (1 год назад )
Выпущено
Nov 27, 2023 (1 год назад )
Обновлено
2 дня назад
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.